Back |
home / stock / fhtx / fhtx message board
Subject | By | Source | When |
---|---|---|---|
Nice, loaded some 17.48. | Surfacetite | investorshub | 12/13/2021 2:42:05 PM |
$FHTX i BOUGHT 4500 SHARES AVG 17.67 | TheFinalCD | investorshub | 12/13/2021 2:40:06 PM |
Sound the foghorn! > Tutes loading shares all day! | crudeoil24 | investorshub | 12/13/2021 2:38:32 PM |
Loaded 17.11's > Going to run 20.00+ today. | crudeoil24 | investorshub | 12/13/2021 2:36:30 PM |
Amazing! Trading float is 17M according to MarketWatch. | crudeoil24 | investorshub | 12/13/2021 2:27:52 PM |
$FHTX As part of the deal, Eli Lilly | TheFinalCD | investorshub | 12/13/2021 2:21:51 PM |
Foghorn Therapeutics Stock Surges After $1.5B Cancer Pact | crudeoil24 | investorshub | 12/13/2021 2:11:45 PM |
Foghorn Therapeutics Inc. is focused on the discovery | crudeoil24 | investorshub | 12/13/2021 2:10:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Foghorn Therapeutics Inc. Company Name:
FHTX Stock Symbol:
NASDAQ Market:
Foghorn Therapeutics Inc. Website:
2024-07-18 00:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-06 14:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced management's participation in the Jeffe...